Glaukos Total Assets 2014-2026 | GKOS

Glaukos total assets from 2014 to 2026. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Glaukos total assets for the quarter ending June 30, 2026 were $0.921B, a 6.73% decline year-over-year.
  • Glaukos total assets for 2025 were $0.893B, a 8.34% decline from 2024.
  • Glaukos total assets for 2024 were $0.975B, a 3.65% increase from 2023.
  • Glaukos total assets for 2023 were $0.94B, a 6.18% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Glaukos Annual Total Assets
(Millions of US $)
2025 $893
2024 $975
2023 $940
2022 $1,002
2021 $1,050
2020 $1,006
2019 $818
2018 $207
2017 $166
2016 $134
2015 $117
2014 $26
2013 $31
Glaukos Quarterly Total Assets
(Millions of US $)
2026-06-30 $921
2026-03-31 $893
2025-12-31 $893
2025-09-30 $999
2025-06-30 $987
2025-03-31 $966
2024-12-31 $975
2024-09-30 $927
2024-06-30 $920
2024-03-31 $933
2023-12-31 $940
2023-09-30 $949
2023-06-30 $957
2023-03-31 $973
2022-12-31 $1,002
2022-09-30 $1,008
2022-06-30 $1,031
2022-03-31 $1,052
2021-12-31 $1,050
2021-09-30 $1,064
2021-06-30 $1,044
2021-03-31 $1,023
2020-12-31 $1,006
2020-09-30 $995
2020-06-30 $996
2020-03-31 $780
2019-12-31 $818
2019-09-30 $307
2019-06-30 $302
2019-03-31 $228
2018-12-31 $207
2018-09-30 $191
2018-06-30 $171
2018-03-31 $163
2017-12-31 $166
2017-09-30 $153
2017-06-30 $146
2017-03-31 $138
2016-12-31 $134
2016-09-30 $129
2016-06-30 $124
2016-03-31 $116
2015-12-31 $117
2015-09-30 $118
2015-06-30 $128
2015-03-31 $28
2014-12-31 $26
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $10.092B $0.507B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.884B 25.75
Intuitive Surgical (ISRG) United States $133.518B 45.26
Edwards Lifesciences (EW) United States $49.242B 30.43
IQVIA Holdings (IQV) United States $43.729B 23.39
Waters (WAT) United States $40.283B 29.97
IDEXX Laboratories (IDXX) United States $40.144B 35.83
Alcon (ALC) Switzerland $33.505B 20.78
DexCom (DXCM) United States $31.955B 33.21
Mettler-Toledo (MTD) United States $25.762B 28.65
STERIS (STE) Ireland $20.832B 20.50
SONOVA HOLDING (SONVY) Switzerland $16.759B 0.00
Hologic (HOLX) United States $16.752B 17.53
Coloplast (CLPBY) Denmark $14.762B 17.70
Penumbra (PEN) United States $12.599B 83.08
Fresenius Medical Care AG KGaA (FMS) Germany $12.279B 8.59
Globus Medical (GMED) United States $10.173B 15.40
Masimo (MASI) United States $9.578B 30.69
SARTORIUS (SSSGY) Germany $7.521B 43.67
Sysmex ADR (SSMXY) Japan $7.390B 27.95
Teleflex (TFX) United States $5.521B 14.89
LivaNova (LIVN) United Kingdom $4.442B 22.46
Integer Holdings (ITGR) United States $4.287B 19.86
Pulse Biosciences (PLSE) United States $3.752B 0.00
Veracyte (VCYT) United States $3.313B 27.11
TransMedics (TMDX) United States $2.967B 43.58
AxoGen (AXGN) United States $2.354B 0.00
UFP Technologies (UFPT) United States $2.153B 27.17
Elekta AB (EKTAY) Sweden $1.883B 17.62
Nihon Kohden (NHNKY) Japan $1.694B 15.52
Alphatec Holdings (ATEC) United States $1.677B 0.00
Alpha Tau Medical (DRTS) Israel $1.301B 0.00
Integra LifeSciences Holdings (IART) United States $1.222B 6.36
Artivion (AORT) United States $1.217B 46.24
PROCEPT BioRobotics (PRCT) United States $1.204B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.171B 27.77
Tandem Diabetes Care (TNDM) United States $1.170B 0.00
OPKO Health (OPK) United States $1.164B 0.00
IRadimed (IRMD) United States $1.055B 46.11
Anteris Technologies Global (AVR) Australia $0.850B 0.00
SiBone (SIBN) United States $0.829B 0.00
Beta Bionics (BBNX) United States $0.753B 0.00
Mesa Laboratories (MLAB) United States $0.680B 16.37
AngioDynamics (ANGO) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.583B 0.00
Delcath Systems (DCTH) United States $0.570B 1644.00
Tactile Systems Technology (TCMD) United States $0.511B 20.90
NeuroPace (NPCE) United States $0.501B 0.00
Sight Sciences (SGHT) United States $0.448B 0.00
Pacific Biosciences Of California (PACB) United States $0.420B 0.00
ClearPoint Neuro (CLPT) United States $0.411B 0.00
908 Devices (MASS) United States $0.402B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.371B 0.00
Mobia Medical (MOBI) United States $0.334B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Treace Medical Concepts (TMCI) United States $0.301B 0.00
Spectral Diagnostics (EDTXF) Canada $0.266B 0.00
RxSight (RXST) United States $0.254B 0.00
Neuronetics (STIM) United States $0.221B 0.00
Lucid Diagnostics (LUCD) United States $0.159B 0.00
FocalTherics (FOCL) France $0.154B 0.00
Inogen (INGN) United States $0.139B 0.00
EDAP TMS S.A (EDAP) France $0.124B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
LENSAR (LNSR) United States $0.096B 0.00
Hyperfine (HYPR) United States $0.085B 0.00
Zomedica (ZOMDF) United States $0.083B 0.00
CVRx (CVRX) United States $0.080B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
Covalon Technologies (CVALF) Canada $0.071B 23.27
DarioHealth (DRIO) United States $0.069B 0.00
Positron (POSC) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.059B 0.00
Envoy Medical (COCH) United States $0.056B 0.00
Nano-X Imaging (NNOX) Israel $0.055B 0.00
Spectral AI (MDAI) United States $0.052B 0.00
Sensus Healthcare (SRTS) United States $0.052B 0.00
Precision Optics (POCI) United States $0.048B 0.00
Baird Medical Investment Holdings (BDMD) $0.045B 0.00
InspireMD (NSPR) United States $0.038B 0.00
QT Imaging Holdings (QTI) United States $0.036B 0.00
PAVmed (PAVM) United States $0.035B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
Accuray (ARAY) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.004B 0.00
ENvue Medical (FEED) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
NexGel (NXGL) United States $0.003B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.000B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00